Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

1.5K
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.5K
Drug Therapy01:28

Drug Therapy

423
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
423
Oral Hypoglycemic Agents: Biguanides and Glitazones01:26

Oral Hypoglycemic Agents: Biguanides and Glitazones

994
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
994
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

1.3K
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
1.3K
Oral Drug Delivery Systems: Continuous-Release Systems01:26

Oral Drug Delivery Systems: Continuous-Release Systems

265
Continuous-release drug delivery systems offer a strategic approach to maintaining therapeutic drug levels over extended periods following oral administration. By modulating the release rate of active pharmaceutical ingredients, these systems minimize fluctuations in plasma concentrations, which enhances clinical efficacy and reduces the need for frequent dosing. Such characteristics make them particularly advantageous in managing chronic diseases where patient adherence and stable drug...
265
Dipeptidyl Peptidase 4 Inhibitors01:23

Dipeptidyl Peptidase 4 Inhibitors

1.1K
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Telephone Outreach Is Associated With Improved Blood Pressure in Patients at an Urban Community Health Center.

Journal of primary care & community health·2026
Same author

Telephone Outreach and Skill-Based Group Education Improves Blood Pressure in Patients at a Community Health Center.

Public health nursing (Boston, Mass.)·2026
Same author

Making Value Visible Through Measurement: Creating Actionable Measurement Maps for Nursing Care Processes and Outcomes.

AACN advanced critical care·2026
Same author

Hidden Structure of Care Coordination in Heart Failure Care Transitions: A Mixed-Method Network Analysis of Clinical Notes.

Journal of cardiac failure·2026
Same author

Using Innovative Software to Address the Puzzle of Sustainable Workforce Stability.

The Journal of nursing administration·2025
Same author

Human-Centered Design of a Virtual Reality Intervention to Promote Early Mobility in a Cardiothoracic ICU.

Computers, informatics, nursing : CIN·2025

Related Experiment Video

Updated: Apr 17, 2026

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

19.5K

Improving diabetes medication adherence: successful, scalable interventions.

Leah L Zullig1, Walid F Gellad2, Jivan Moaddeb3

  • 1Center for Health Services Research in Primary Care, Durham Veterans Affairs Medical Center, Durham, NC, USA ; Department of Medicine, Duke University, Durham, NC, USA.

Patient Preference and Adherence
|February 12, 2015
PubMed
Summary
This summary is machine-generated.

Many patients struggle with medication adherence, posing a significant public health challenge. This study identifies effective and scalable interventions to improve medication adherence, particularly for diabetes patients, offering low-resource solutions for healthcare systems.

Keywords:
chronic diseasediabetes mellitusdissemination researchimplementation researchmedication adherencereview

More Related Videos

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

5.4K
Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

1.5K

Related Experiment Videos

Last Updated: Apr 17, 2026

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

19.5K
Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

5.4K
Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

1.5K

Area of Science:

  • Public Health
  • Health Services Research
  • Pharmacoeconomics

Background:

  • Medication adherence is crucial for disease prevention and treatment effectiveness.
  • Poor medication adherence affects approximately half of patients, creating a substantial public health issue in the US.
  • The complexity of medication adherence necessitates multifaceted, scalable solutions.

Purpose of the Study:

  • To identify effective and scalable interventions for improving medication adherence in patients with diabetes.
  • To characterize the key features that contribute to the effectiveness and scalability of these interventions.
  • To provide actionable insights for healthcare systems aiming to enhance medication adherence with cost-effective, low-resource strategies.

Main Methods:

  • Review and synthesis of existing literature on medication adherence interventions.
  • Focus on interventions demonstrated to be effective in improving adherence among diabetes patients.
  • Assessment of intervention scalability for broad implementation within healthcare systems.

Main Results:

  • Identification of specific interventions proven effective for improving medication adherence in diabetes.
  • Characterization of intervention attributes that facilitate large-scale adoption and implementation.
  • Highlighting of low-resource, cost-effective strategies suitable for diverse healthcare settings.

Conclusions:

  • Effective and scalable interventions can significantly improve medication adherence in diabetes.
  • Understanding intervention characteristics is key for successful implementation in healthcare systems.
  • Low-resource, cost-effective solutions are vital for addressing the public health challenge of medication non-adherence.